Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Shape Vantage

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Shape Vantage head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 523 · Grade C

Shape Vantage

Visit Shape Vantage Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 48 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Shape Vantage a bad call — it's best for readers who can verify the clinician, pharmacy and preparation. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
42
Transparency
90
72
Access Breadth
93
40
Clinical Oversight
92
36
Track Record
88
25
CoreAge RxBrief Score 94 · 48Shape Vantage

Price, coverage & the tracker

CoreAge RxShape Vantage
Brief Score94/100 (A)48/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Ask whether this option is offered.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$399 advertised for a three-month kit labeled tirzepatide.

CoverageUS only; restrictions by state, confirmed at intakeConfirm the clinical and pharmacy pathway for your address.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Shape Vantage: Confirm clinical review and the exact formulation.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.